These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 390331)

  • 1. The regulation of prostaglandin E1 formation: a candidate for one of the fundamental mechanisms involved in the actions of vitamin C.
    Horrobin DF; Oka M; Manku MS
    Med Hypotheses; 1979 Aug; 5(8):849-58. PubMed ID: 390331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sjogren's syndrome and the sicca syndrome: the role of prostaglandin E1 deficiency. Treatment with essential fatty acids and vitamin C.
    Horrobin DF; Campbell A
    Med Hypotheses; 1980 Mar; 6(3):225-32. PubMed ID: 7432243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential regulation of the formation of prostaglandins and related substances from arachidonic acid and from dihomogammalinolenic acid. II. Effects of vitamin C.
    Manku MS; Oka M; Horrobin DF
    Prostaglandins Med; 1979 Aug; 3(2):129-37. PubMed ID: 552100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sjögren's syndrome in scurvy.
    Hood J; Burns CA; Hodges RE
    N Engl J Med; 1970 May; 282(20):1120-4. PubMed ID: 5439409
    [No Abstract]   [Full Text] [Related]  

  • 5. A biochemical basis for alcoholism and alcohol-induced damage including the fetal alcohol syndrome and cirrhosis: interference with essential fatty acid and prostaglandin metabolism.
    Horrobin DF
    Med Hypotheses; 1980 Sep; 6(9):929-42. PubMed ID: 6253773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclic adenosine 3',5'-monophosphate inhibits the availability of arachidonate to prostaglandin synthetase in human platelet suspensions.
    Minkes M; Stanford N; Chi MM; Roth GJ; Raz A; Needleman P; Majerus PW
    J Clin Invest; 1977 Mar; 59(3):449-54. PubMed ID: 190267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin C.
    Catalano PM
    Arch Dermatol; 1971 May; 103(5):537-9. PubMed ID: 4931650
    [No Abstract]   [Full Text] [Related]  

  • 8. Possible role of prostaglandin E1 in the affective disorders and in alcoholism.
    Horrobin DF; Manku MS
    Br Med J; 1980 Jun; 280(6228):1363-6. PubMed ID: 7388546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of Sjogren's syndrome with essential fatty acids, pyridoxine and vitamin C.
    McKendry RJ
    Prostaglandins Leukot Med; 1982 Apr; 8(4):403-8. PubMed ID: 6955809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new concept of lifestyle-related cardiovascular disease: the importance of interactions between cholesterol, essential fatty acids, prostaglandin E1 and thromboxane A2.
    Horrobin DF
    Med Hypotheses; 1980 Aug; 6(8):785-800. PubMed ID: 7003328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism of gammalinolenic acid by human blood platelet microsomes.
    de Bravo MM; De Tomás ME; Mercuri O
    Biochem Int; 1985 Jun; 10(6):889-96. PubMed ID: 2994669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of feeding ethyl-dihomo-gamma-linolenate on prostaglandin biosynthesis and platelet aggregation in the rabbit.
    Oelz O; Seyberth HW; Knapp HR; Sweetman BJ; Oates JA
    Biochim Biophys Acta; 1976 May; 431(2):268-77. PubMed ID: 938654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The nutritional regulation of T lymphocyte function.
    Horrobin DF; Manku MS; Oka M; Morgan RO; Cunnane SC; Ally AI; Ghayur T; Schweitzer M; Karmali RA
    Med Hypotheses; 1979 Sep; 5(9):969-85. PubMed ID: 316494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostaglandin E precursor fatty acids inhibit human IL-2 production by a prostaglandin E-independent mechanism.
    Santoli D; Zurier RB
    J Immunol; 1989 Aug; 143(4):1303-9. PubMed ID: 2545787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antithrombotic potential of dihomo-gamma-linolenic acid in man.
    Kernoff PB; Willis AL; Stone KJ; Davies JA; McNicol GP
    Br Med J; 1977 Dec; 2(6100):1441-4. PubMed ID: 338112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased synthesis of prostaglandin-E-like material by platelets from patients with diabetes mellitus.
    Halushka PV; Lurie D; Colwell JA
    N Engl J Med; 1977 Dec; 297(24):1306-10. PubMed ID: 917087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Essential fatty acid metabolism in diseases of connective tissue with special reference to scleroderma and to Sjogren's syndrome.
    Horrobin DF
    Med Hypotheses; 1984 Jul; 14(3):233-47. PubMed ID: 6088955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation on a selective non-prostanoic thromboxane antagonist, BM 13.177, in human platelets.
    Patscheke H; Stegmeier K
    Thromb Res; 1984 Feb; 33(3):277-88. PubMed ID: 6424261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of prostaglandin E1 in collagen disease patients with inflammatory skin ulcer.
    Tohjima T; Shiokawa Y
    Int J Tissue React; 1983; 5(1):1-10. PubMed ID: 6683263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of antioxidant nutrients on platelet function in healthy volunteers.
    Calzada C; Bruckdorfer KR; Rice-Evans CA
    Atherosclerosis; 1997 Jan; 128(1):97-105. PubMed ID: 9051202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.